Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting
- Tuesday, September 5, 2023, 7:01
- Finance
- Add a comment
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that it will be presenting a poster at the 2023 European Association…
About the Author
adminasapcorp has written 39059 stories on this site.